Amorphous spironolactone-hydroxypropylated cyclodextrin complexes with superior dissolution and oral bioavailability
Authors:
- Osama Abd Elazeem SolimanOSOsama Abd Elazeem Soliman
- Kenya KimuraKKKenya Kimura
- Fumitoshi HirayamaFHFumitoshi Hirayama
- Kaneto UekamaKUKaneto Uekama
- Hassan Mohamed El-SabbaghHEHassan Mohamed El-Sabbagh
- Abd El-Gawad Helmy Abd El-GawadAEAbd El-Gawad Helmy Abd El-Gawad
- Fahima Mahmoud HashimFHFahima Mahmoud Hashim
- 1 April 1997
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 149 (1) , 73-83
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Carbon-13 Nuclear Magnetic Resonance Study of Naproxen Interaction with Cyciodextrins in SolutionJournal of Pharmaceutical Sciences, 1991
- Polymorphism of SpironolactoneJournal of Pharmaceutical Sciences, 1991
- Carbon-13 CP/MAS NMR studies of amylose inclusion complexes, cyclodextrins, and the amorphous phase of starch granules: relationships between glycosidic linkage conformation and solid-state carbon-13 chemical shiftsJournal of the American Chemical Society, 1988
- Solubilization of drugs by modified β-cyclodextrinsInternational Journal of Pharmaceutics, 1985
- A cross-polarisation-magic-angle spinning 13C-n.m.r. study of solid-state cycloamylose inclusion-complexes with substituted benzenes: 13C-chemical shifts and molecular dynamics of the included guestsCarbohydrate Research, 1984
- Effect of Micronization on the Bioavailability and Pharmacologic Activity of SpironolactoneThe Journal of Clinical Pharmacology, 1982
- Carbon-13 nuclear magnetic resonance studies of spironolactone and several related steroidsSteroids, 1980
- Factors Influencing Comparative Bioavailability of Spironolactone TabletsJournal of Pharmaceutical Sciences, 1977
- AVAILABILITY OF SPIRONOLACTONE GIVEN BY MOUTHThe Lancet, 1962
- Solutions for Maintaining Constant Relative HumidityIndustrial & Engineering Chemistry, 1949